Cacicedo, M. L., Weinl-Tenbruck, C., Frank, D., Wirsching, S., Straub, B. K., Hauke, J., . . . Gehring, S. (2022). mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model. Molecular therapy. Methods & clinical development, 26, . https://doi.org/10.1016/j.omtm.2022.07.006
Chicago-Zitierstil (17. Ausg.)Cacicedo, Maximiliano L., et al. "MRNA-based Therapy Proves Superior to the Standard of Care for Treating Hereditary Tyrosinemia 1 in a Mouse Model." Molecular Therapy. Methods & Clinical Development 26 (2022). https://doi.org/10.1016/j.omtm.2022.07.006.
MLA-Zitierstil (9. Ausg.)Cacicedo, Maximiliano L., et al. "MRNA-based Therapy Proves Superior to the Standard of Care for Treating Hereditary Tyrosinemia 1 in a Mouse Model." Molecular Therapy. Methods & Clinical Development, vol. 26, 2022, https://doi.org/10.1016/j.omtm.2022.07.006.